Logo
Smith Gemini
https://www.creative-biola...
Tumor profiling has transformed brain cancer research by identifying key biomarkers like CD133, nestin, and UCH-L1, offering insights into tumor heterogeneity, progression, and resistance. Despite challenges like the blood-brain barrier, Creative Biolabs overcame these with multi-omics integration and constructed our Tumor Profiling to Guide Targeted Cancer Therapy Platforms. Our services empower researchers to make informed decisions, driving innovation in brain cancer research.
2 months ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Smith Gemini, click on at the bottom under it